Animal diseases, such as avian influenza or African swine fever, know no borders and can continually affect new areas. Reducing the risk is possible through the implementation of procedures designed to avoid the introduction and spread of pathogens in animal populations.
Under the leadership of Pirbright’s Dr Elma Tchilian the Comparative and Veterinary Immunology Group (CVIG) has been revived and is actively engaging in opportunities to showcase the research of its members and bring knowledge of comparative and veterinary immunology to a wider audience.
Last week, The 19th International Symposium of World Association of the Veterinary Laboratory Diagnosticians and OIE Seminar (19th ISWAVLD 2019) Press Conference event held on Wednesday 12th September, 2018 (13.00-15.30 hrs.) at MR 220, BITEC, Bangkok, Thailand during Thailand LAB INTERNATIONAL 2018.
A vaccine launched five years ago has now protected over 47 million European pigs against a lethal and debilitating ailment.
The “PRRS Disease Research Project Results Conference” cohosted by Hvsen Biotech and Wuhan Xinhuaxing (Wuhan Station) was held in the International Academic Exchange Center of Huazhong Agricultural University.
Vaccination against oedema disease is now protecting over ten per cent of pigs in some countries.
Eli Lilly and Company today announced that the company has completed its strategic review of Elanco Animal Health, and will file a registration statement in the coming weeks with the U.S. Securities and Exchange Commission (SEC) for a potential initial public offering (IPO) of a minority ownership stake in Elanco as a separate company.
Discover the 39 awarded exhibitors Innov'Space 2018 selected by the jury of experts. 30 received 1 star, and 9 received 2 stars.